Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | TYMP | P19971 | 6/20 | 0.43 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.37 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.37 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.35 |
| ▸ | POLA1 | P09884 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31724038 | 0.94 | KDM4E (0.48) | KDM4ETYMPTAS1R3TAS1R1P2RY1 | |
| SCHEMBL31724044 | 0.89 | KDM4E (0.48) | KDM4ETYMPTAS1R3TAS1R1P2RY1 | |
| SCHEMBL3820892 | 0.88 | KDM4E (0.56) | KDM4ETYMPTAS1R3TAS1R1P2RY1 | |
| SCHEMBL10788490 | 0.86 | KDM4E (0.49) | KDM4ETYMPTAS1R3TAS1R1P2RY1 | |
| SCHEMBL26190487 | 0.86 | KDM4E (0.53) | KDM4ETYMPTAS1R3TAS1R1POLA1 | |
| SCHEMBL21828783 | 0.86 | KDM4E (0.53) | KDM4ETYMPTAS1R3TAS1R1P2RY1 | |
| SCHEMBL17911710 | 0.86 | KDM4E (0.53) | KDM4ETYMPTAS1R3TAS1R1P2RY1 | |
| SCHEMBL14063336 | 0.86 | KDM4E (0.53) | KDM4ETYMPTAS1R3TAS1R1P2RY1 | |
| SCHEMBL14062506 | 0.86 | KDM4E (0.53) | KDM4ETYMPTAS1R3TAS1R1P2RY1 | |
| SCHEMBL12714672 | 0.85 | TYMP (0.59) | KDM4ETYMPTAS1R3TAS1R1POLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4532724-A1 | LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | Ionis Pharmaceuticals, Inc. (US) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023235817-A1 | LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2023-12-07 | — | — | WO | disclosed |